Catalyst Pharmaceuticals Inc (CPRX)
14.71
-0.31
(-2.06%)
USD |
NASDAQ |
May 03, 16:00
14.71
0.00 (0.00%)
After-Hours: 20:00
Catalyst Pharmaceuticals 1 Year Total Returns (Daily): -9.63% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 02, 2024 | -9.63% |
May 01, 2024 | -10.27% |
April 30, 2024 | -5.46% |
April 29, 2024 | -4.33% |
April 26, 2024 | -7.05% |
April 25, 2024 | -8.76% |
April 24, 2024 | -8.47% |
April 23, 2024 | -10.62% |
April 22, 2024 | -8.37% |
April 19, 2024 | -12.69% |
April 18, 2024 | -13.92% |
April 17, 2024 | -11.50% |
April 16, 2024 | -12.15% |
April 15, 2024 | -13.00% |
April 12, 2024 | -13.28% |
April 11, 2024 | -9.91% |
April 10, 2024 | -8.00% |
April 09, 2024 | -9.15% |
April 08, 2024 | -10.76% |
April 05, 2024 | -10.40% |
April 04, 2024 | -9.89% |
April 03, 2024 | -8.56% |
April 02, 2024 | -7.96% |
April 01, 2024 | -5.07% |
March 28, 2024 | -2.63% |
Date | Value |
---|---|
March 27, 2024 | -1.03% |
March 26, 2024 | -2.30% |
March 25, 2024 | -1.61% |
March 22, 2024 | -2.96% |
March 21, 2024 | 0.54% |
March 20, 2024 | 3.11% |
March 19, 2024 | 2.95% |
March 18, 2024 | 1.00% |
March 15, 2024 | 12.06% |
March 14, 2024 | 9.02% |
March 13, 2024 | 13.60% |
March 12, 2024 | 10.66% |
March 11, 2024 | 9.97% |
March 08, 2024 | 5.93% |
March 07, 2024 | 9.84% |
March 06, 2024 | 5.03% |
March 05, 2024 | 5.31% |
March 04, 2024 | 8.03% |
March 01, 2024 | 10.03% |
February 29, 2024 | 5.05% |
February 28, 2024 | -4.59% |
February 27, 2024 | -6.70% |
February 26, 2024 | -7.08% |
February 23, 2024 | -8.12% |
February 22, 2024 | -9.62% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-56.93%
Minimum
Sep 11 2020
265.6%
Maximum
Jan 20 2023
45.80%
Average
35.75%
Median
1 Year Total Returns (Daily) Benchmarks
Pfizer Inc | -25.37% |
Sarepta Therapeutics Inc | 5.57% |
PTC Therapeutics Inc | -38.84% |
Corcept Therapeutics Inc | 12.01% |
Cytokinetics Inc | 72.55% |